- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/073 - Embryonic cells or tissuesFoetal cells or tissues
Patent holdings for IPC class C12N 5/073
Total number of patents in this class: 1453
10-year publication summary
|
110
|
117
|
105
|
123
|
132
|
132
|
118
|
116
|
89
|
53
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Celularity, Inc. | 185 |
43 |
| Osiris Therapeutics, Inc. | 104 |
28 |
| Accelerated Biosciences Corp. | 39 |
21 |
| ViaCyte, Inc. | 181 |
21 |
| Anthrogenesis Corporation | 75 |
16 |
| Pluri Biotech Ltd. | 54 |
15 |
| Kyoto University | 2798 |
13 |
| CellResearch Corporation Pte Ltd. | 58 |
13 |
| The Regents of the University of California | 19857 |
12 |
| Pluristem Ltd. | 40 |
12 |
| Cambridge Enterprise Limited | 1182 |
11 |
| President and Fellows of Harvard College | 5964 |
10 |
| Astellas Institute for Regenerative Medicine | 119 |
10 |
| University Health Network | 1038 |
10 |
| Children's Hospital Medical Center | 708 |
9 |
| Inguran, LLC | 216 |
9 |
| MiMedx Group, Inc. | 208 |
9 |
| Stemnion, Inc. | 61 |
9 |
| Centre National de La Recherche Scientifique | 10408 |
8 |
| California Institute of Technology | 3973 |
8 |
| Other owners | 1166 |